Natsume A, Arakawa Y, Narita Y, Sugiyama K, et al. The first-in-human phase I study of a brain penetrant mutant IDH1 inhibitor DS-1001 in patients with recurrent or progressive IDH1-mutant gliomas. Neuro Oncol 2022 Jun 20. pii: 6611503. doi: 10.1093.
PMID: 35722822